Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 14 ... agents used in patient care. Importantly, M44-A2 provides testing guidelines for caspofungin as well as interpretive criteria for caspofungin and ...
Subject: Clinical and Laboratory Standards Institute CLSI
2009 OCT 5 ... B lipid formulations in combination with surgery and, perhaps, the addition of caspofungin offers the best chance for survival; posaconazole, a new antifungal triazole, is ...
2009 SEP 7 ... All isolates were susceptible to amphotericin B, voriconazole, posaconazole, and caspofungin; five strains (9%) had fluconazole MIC values of 16-32 mg/L," wrote S.C.A. Chen and ...
2009 NOV 16 ... Candida albicans, C. tropicalis, and C. parapsilosis, was evaluated, and the effect of caspofungin (CAS) was assessed using a clinically relevant in vitro model system," researchers in ...
2009 SEP 8 ... of this pathway in the fungus. msb2 mutants display altered sensitivity to Congo red, caspofungin, zymolyase, or tunicamycin, indicating that this protein is involved in cell wall ...
2009 SEP 28 ... 3.17; P = .010), diabetes mellitus (OR, 8.11; P<.001), and prior voriconazole and/or caspofungin use (OR, 4.41; P = .033) were associated with a higher risk of zygomycosis, whereas ...
2009 NOV 16 ... from Afyon, Turkey, "The purpose of the study was to evaluate the effectiveness of caspofungin and voriconazole in the treatment of experimental Aspergillus otits media in an ...
2009 AUG 31 ... azoles or polyenes. Few studies have directly compared the three approved echinocandins (caspofungin, micafungin, and anidulafungin) for efficacy, but the existing data have not suggested ...
2009 SEP 14 ... to fluconazole, voriconazole, posaconazole, amphotericin B, and two echinocandins, caspofungin and anidulafungin. Of the 175 isolates tested, 160 (91.4%) were identified as C. ...
2009 NOV 16 ... criterion. In contrast, most fks mutants (92%) exceeded a MIC of > 2 mu g/ml with caspofungin. However, when MIC determinations were performed in the presence of 50% serum, all C. ...
2009 NOV 2 ... concluded: "Newly available drugs as those in the echinocandin class include caspofungin, micafungin and anidulafungin, as well as the newer generation triazoles, voriconazole ...
2009 NOV 2 ... conducted a study "To evaluate the cost-effectiveness of micafungin compared to caspofungin in the treatment of systemic Candida infections (SCIs) in the UK, including invasive ...
2009 SEP 28 ... mutants to CW-11 suggests that its mode of action differs from that of the antifungals caspofungin and voriconazole," wrote G. Mircus and colleagues, Tel-Aviv University. ...
2009 OCT 5 ... P. falciparum malaria is presented, who was successfully treated with voriconazol and caspofungin," wrote I. Eckerle and colleagues, University of Heidelberg. The ...
2009 NOV 16 ... 2009) was conducted for articles published in the English language using the key words caspofungin, micafungin, anidulafungin, and echinocandins." "AND DATA EXTRACTION: ...
2009 SEP 7 ... (mean dose 3.7 mg/kg/day). The drug was used as rescue treatment after fluconazole or caspofungin in 47% of patients and as firstline in 52% with a satisfactory clinical response in 54% ...
2009 NOV 1 ... most Candida spp. In several randomised multicentre phase III trials, anidulafungin, caspofungin and micafungin showed convincing efficacy when compared with standard treatment ...
2009 NOV 1 ... (DOX), alone or in combination with standard concentrations of amphotericin B (AMB), caspofungin (CAS) or fluconazole (FLC), against biofilms formed by Candida albicans in vitro," ...
